Tumor-Specific Mutations More Common in High-Grade Neuroendocrine Tumors
Tumor-specific mutations are common in high-grade neuroendocrine tumors.
Tumor-specific mutations are common in high-grade neuroendocrine tumors.
A 3-marker immunohistochemistry panel helps determine the primary site of malignancy in metastatic neuroendocrine tumors.